Anne-Marie de Groot
Nessuna posizione attualmente
Storia della carriera di Anne-Marie de Groot
Precedenti posizioni note di Anne-Marie de Groot
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PHARMING GROUP N.V. | Responsabile della Conformità | 15/12/2020 | 01/05/2021 |
| Corporate Officer/Principal | 01/01/2014 | 15/12/2020 | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/01/2016 | 01/01/2019 |
Formazione di Anne-Marie de Groot
| Stichting Hogeschool Leiden | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Paesi Bassi | 3 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Compliance Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Anne-Marie de Groot
- Esperienza